NEW YORK -- The world market for products to treat burn wounds stands at more than $1.5 billion and will surpass the $2 billion mark in the next few years, according to a new study released today from Kalorama Information. Leading the growth in burn care are several market segments, including silver dressings and portions of the biological dressings sector, both of which will display annual growth in excess of 20 percent through the end of the decade.
The new study, Wound Care Markets, Volume II: Burns, found that after a few years of slowing momentum, the burn-care segment has begun to stabilize. However, emerging technologies and approaches to burn care will continue to push the dynamic market forward.
"After a decline in growth in 2000, the market appears to be settling," notes Mary Anne Crandall, the author of the report. "However, burn care will continue to experience a few ups and downs due to price constraints, new technologies, and additional market penetration by emerging therapeutics."
The study examines six broad categories of products-anti-infectives, burn management products, moist dressings, biological dressings, pressure relief devices, and other miscellaneous treatments-and more than 10 subcategories, including cleansers, debridement products, silver dressings, alginates, films, foams, hydrocolloids, hydrogels, artificial skins, collagen products, and others.
In addition to a thorough analysis of market size and growth through 2009 for each segment and subsegment, the study details competitive market share in each segment and provides a thorough understanding of the clinical and reimbursement environment in which these wound care manufacturers operate.
Source: Kalorama Information, a division of MarketResearch.com
Strengthening Defenses: Integrating Infection Control With Antimicrobial Stewardship
October 11th 2024Use this handout to explain the basics of why infection prevention and control and antimicrobial stewardship are essential and how the 2 fields must have a unified approach to patient and staff safety
Blood Product Overtransfusion Is a Global Issue: Here Are 5 Reasons the Practice Must Change
October 9th 2024If a patient receives treatment or therapy that they do not need, it can cause unnecessary harm. This is true for medications, surgeries, and medical procedures, especially blood transfusions.
Pseudomonas aeruginosa: Infection Risks, Challenges, and Breakthroughs for Health Care Professionals
September 19th 2024Pseudomonas aeruginosa, a highly virulent pathogen, poses significant risks to immunocompromised patients, presenting challenges in treatment due to its antibiotic resistance and environmental persistence.